Journal profile · Infectious Diseases
HIV Medicine
ISSN 1464-2662 · eISSN 1468-1293 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 1999
HIV Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.2; hybrid open access; APC about USD 4,150; median 104 days to acceptance (99 articles, last 24 months); community-reported acceptance: moderate; 221 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
HIV Medicine is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV/AIDS Research and Interventions, HIV-related health complications and treatments and HIV/AIDS drug development and treatment, together about 55.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating people living with HIV. Keywords HIV Medicine, HIV, AIDS, autoimmune deficiency syndrome, retroviruses, STD, clinical therapies Abstracting and Indexing Information Abstracts in Anthropology (Sage) Abstracts on Hygiene & Communicable Diseases (CABI) Academic Search (EBSCO Publishing) Academic Search Alumni Edition (EBSCO Publishing) Academic Search Elite (EBSCO Publishing) Academic Search Premier (EBSCO Publishing) Botanical Pesticides (CABI) CAB Abstracts® (CABI) Current Contents: Clinical Medicine (Clarivate Analytics) Dairy Science Abstracts (CABI) Embase (Elsevier) Gender Studies Collection (GALE Cengage) Global Health (CABI) Health Source Nursing/Academic (EBSCO Publishing) HEED: Health Economic Evaluations Database (Wiley-Blackwell) Helminthological Abstracts (CABI) Journal Citation Reports/Science Edition (Clarivate Analytics) Leisure Tourism Database (CABI) Leisure, Recreation & Tourism Abstracts (CABI) MEDLINE/PubMed (NLM) Nutrition Abstracts & Reviews Series A: Human & Experimental (CABI) Protozoological Abstracts (CABI) PubMed Dietary Supplement Subset (NLM) Review of Aromatic & Medicinal Plants (CABI) Review of Medical & Veterinary Entomology (CABI) Review of Medical & Veterinary Mycology (CABI) Rural Development Abstracts (CABI) Science Citation Index Expanded (Clarivate Analytics) Tropical Diseases Bulletin (CABI)
From the journal's Aims & Scope
Research area (LetPub): Infectious Diseases
Editor-in-chief Caroline SabinPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 2, Switzerland 2, South Africa 2, Germany 1, Spain 1 (9 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV/AIDS Research and InterventionsMedicine22%
- HIV-related health complications and treatmentsMedicine17.1%
- HIV/AIDS drug development and treatmentMedicine16.4%
- HIV Research and TreatmentImmunology and Microbiology15.3%
- HIV, Drug Use, Sexual RiskMedicine5%
- Pneumocystis jirovecii pneumonia detection and treatmentMedicine3.9%
- Hepatitis C virus researchMedicine3%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance1.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Infectious Diseases | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.2LetPub ·
- Impact factor (publisher)
- 3.2Publisher website ·
- Impact factor (publisher) 2025
- 3.2Publisher website ·
- CiteScore 2026-06
- 5.6LetPub ·
- CiteScore (publisher)
- 5.6Publisher website ·
- CiteScore (publisher) 2025
- 5.6Publisher website ·
- SJR 2026-06
- 1.06LetPub ·
- SNIP 2026-06
- 1.11LetPub ·
- h-index
- 73LetPub ·
- h-index
- 102OpenAlex ·
- i10-index
- 1,479OpenAlex ·
- 2-year mean citedness
- 2.06OpenAlex ·
- Self-citation rate
- 6.2%LetPub ·
- Share of gold OA articles
- 57.07%LetPub ·
Volume
- Articles per year
- 161LetPub ·
- Articles per year (publisher) 2025
- 178Publisher website ·
- Downloads per year (publisher) 2025
- 448,209Publisher website ·
Articles by year OpenAlex count · 3,471 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 143 | 97 | 23 |
| 2025 | 221 | 149 | 458 |
| 2024 | 168 | 128 | 617 |
| 2023 | 168 | 127 | 1,203 |
| 2022 | 186 | 90 | 2,098 |
| 2021 | 191 | 85 | 1,715 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
104 daysMedian, submission to acceptance · P25–P75 71 days – 156 days
- Acceptance to online
- median 15 days (100 articles)
- Submission to online
- median 121 days
- Sample
- 99 articles with submission and acceptance dates (378 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance rate (publisher)
- 33%Publisher website ·
- Acceptance rate (publisher) 2025
- 33%Publisher website ·
- Submission to first decision
- 17 daysPublisher website ·
- Submission to first decision 2025
- 17 daysPublisher website ·
- Submission to acceptance 2025
- 92 daysPublisher website ·
- Acceptance to publication 2025
- 15 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / EUR 3,470 / GBP 2,780 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 5
- Manuscript length
- ≤ 3,500 words
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
- Not considered
- Case Reports; Purely basic science papers
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Peer review
- Authorship
Copyright transfer to British HIV Association on acceptance. Model summary
All accepted papers become the copyright of the British HIV Association.
Source ↗Publisher website ·- Data availability Data Sharing
This journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- Publication ethics
COPE membership. Model summary
The Journal is a member of the Committee on Publication Ethics (COPE) and abides by its principles.
Source ↗Publisher website ·- Peer review
Proofs via HTML page proofs online. Model summary
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1999
- ISSN
- 1464-2662
- Electronic ISSN
- 1468-1293
- Latest issue on the website
- Volume 27, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about HIV Medicine
What CAS zone is HIV Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, HIV Medicine is in Zone 3 of Medicine, and in Zone 3 of the minor category Infectious Diseases. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of HIV Medicine?
The latest impact factor listed by LetPub is 3.2; CiteScore 5.6, h-index 102.
How long does peer review take at HIV Medicine?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 104 days (interquartile range 71–156 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”; the journal's website gives an acceptance rate of 33% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of HIV Medicine?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 5; Manuscript length: ≤ 3,500 words; Reference style: Author–date; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of HIV Medicine based?
Of the 9 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (2), Switzerland (2) and South Africa (2). Counted from the institutions listed on the board page; for reference only.
Which databases index HIV Medicine?
According to LetPub and DOAJ records, HIV Medicine is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is HIV Medicine open access, and what is the APC?
HIV Medicine is a hybrid journal. For open-access publication: APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .